BIOTIME, INC. SC 13D 12-30-2015 (ONCOCYTE CORPORATION)

Company

Lineage Cell Therapeutics, Inc.

Filed

December 31, 2015

Accession Number

0001140361-15-046080

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →